SGLT2 Inhibitors Market 2030: Executive Summary, Key Trends & Future Outlook
SGLT2 Inhibitors Market Size & Insights
The Global SGLT2 Inhibitors Market size was valued at around USD 18.41 billion in 2024 and is projected to reach USD 30.34 billion by 2030. Along with this, the market is estimated to grow at a CAGR of around 8.68% during the forecast period, i.e., 2025-30.
The SGLT2 Inhibitors Market is significantly growing due to several growth factors, including the rapidly growing gaming industry, the rising demand for electronic devices, including TVs, smartphones, monitors, wearables, etc., the infrastructural development & expansion of production facilities, and the integration of artificial intelligence in SGLT2 Inhibitors.
What are the Key DROs in the SGLT2 Inhibitors Market?
High Prevalence of Chronic Diseases – The market demand is driven by the high burden of chronic disorders globally, especially cardiovascular diseases, chronic disorders, and type 2 diabetes. For instance, as per the International Diabetes Federation (2021), there were over 540 million adult patients with type 2 diabetes globally, which is further expected to reach more than 640 million. Similarly, chronic kidney disease (CKD) is also highly prevalent globally, accounting for more than 840 million individuals all around the world. Also, more than 65 million individuals experience heart failure globally.
These are increasing the demand for advanced medication such as the SGLT2 Inhibitors, which can inhibit the action of the SGLT2 protein and are highly effective in overcoming these diseases, thus increasing market growth. It has led to the expansion of the SGLT2-inhibitor-based drugs' active pharmaceutical ingredient plants (API) worldwide. For instance, there are about 40-50 API plants globally that are specific to SGLT2 inhibitors.
What are the Key Segments in the SGLT2 Inhibitors Market?
The SGLT2 Inhibitors is categorized into notable segments, which help in understanding the structure, dynamics, and opportunities within the market. These segments are typically based on:
-By Application
Type 2 Diabetes- Market Size & Forecast 2020-2030, USD Million
Cardiovascular- Market Size & Forecast 2020-2030, USD Million
Chronic Kidney Disease (CKD) - Market Size & Forecast 2020-2030, USD Million
Others- Market Size & Forecast 2020-2030, USD Million
-By Drug Type
Jardiance (empagliflozin)
Farxiga (dapagliflozin)
Invokana (canagliflozin)
Inpefa (sotagliflozin)
Qtern (dapagliflozin/saxagliptin)
Others
Among these, the Jardiance (empagliflozin) holds the largest market share of about 32%. The dominance of this drug type is due to the high clinical performance over other kinds of drugs, proven by the large-scale clinical trials such as the EMPA-REG, DAPA-HF, and CREDENCE.
-By End-User
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Out of these, Hospital Pharmacies are dominating the Global SGLT2 Inhibitors Industry with a market share of more than 60%.
How does geographical analysis highlight in the Saudi Arabia Online Grocery Delivery market?
-By Region
North America
South America
Europe
The Middle East & Africa
Asia-Pacific
North America holds the largest market share of more than 42%. The major reason behind its growth is the rising number of patients, especially the elderly population in the region, which is highly vulnerable to chronic diseases.
Who are the Key Players in SGLT2 Inhibitors Market?
Astellas
AstraZeneca
Boehringer Ingelheim International
Bristol-Myers Squibb Company
Eli Lilly and CompanyGlenmark Pharmaceuticals
Johnson & Johnson (Janssen Pharmaceuticals)
Lexicon Pharmaceuticals
Lupin Limited
Merck
Sanofi
Others
SGLT2 Inhibitors Market News
2024: Eli Lilly and Company launched a new combination therapy, bringing together its SGLT2 inhibitor Jardiance (empagliflozin) with a GLP-1 agonist. This new treatment helps improve blood sugar control and supports weig ht loss in people with type 2 diabetes, offering a more effective option for managing the condition.
Key pillars of the research methodology include:
Scope & Research Design – Clearly defined objectives with tailored qualitative and quantitative methods, backed by precise timelines and budgets.
Sample Selection & Data Collection – Representative samples achieved through proven techniques like random and stratified sampling, supported by reliable tools such as surveys, interviews, and observations.
Data Analysis & Validation – Rigorous cleaning, advanced statistical modeling, and thematic analysis ensure accuracy, reliability, and minimal bias.
Forecasting & Finalization – Predictive modeling and time-series analysis anticipate future market behaviors, presented through insightful reports with charts, graphs, and strategic recommendations.
"Our methodology reflects the trust businesses place in us. By combining innovation with precision, we deliver not just numbers, but clarity and direction for decision-makers worldwide," said a spokesperson for MarkNtel Advisors.
Why This MarkNtel Advisors Research Report:
In-depth Market Analysis: Understand trends and dynamics shaping growth.
Segmented Insights: Target specific segments for focused strategies.
Geographical Performance: Assess market opportunities by geographic area.
Emerging Technologies: Discover advancements like AI integration.
Risk Identification: Pinpoint challenges to inform strategic planning.
Future Forecasts: Prepare for market changes with actionable projections.
Gain exclusive access to our comprehensive insights on the Future of SGLT2 Inhibitors Market. With tailored licensing options, including Mini Report Pack, Excel Data Pack, Single User, Multiuser, and Enterprise Packs, our research empowers organizations to navigate dynamic market trends effectively.
Our Trusted Experts Are Here to Help:
At MarkNtel Advisors, we are committed to delivering data-driven insights and strategic intelligence that empower your business decisions. Whether you have a question, need customized research, or want to explore partnership opportunities, our team is here to support you every step of the way.
Reach Us:
MarkNtel Advisors
Office No.109, H-159, Sector 63, Noida, Uttar Pradesh-201301, India
Contact No: +91 8719999009
Email: sales@marknteladvisors.com
Visit our Website: https://www.marknteladvisors.com